Back before Omar Ishrak retired last year as the chief executive of Medtronic PLC, run out of Fridley, it's unlikely the board ever gave him $15 million to buy whatever he wanted.
Yet Medtronic seems ready to give that to him now that he's the co-founder and chairman of the board of something called Compute Health Acquisition Corp.
What Compute Health will do with Medtronic's money can't be known, because this is a special purpose acquisition company, usually called a SPAC or a blank check company.
It's going public without a business, so there's nothing to analyze or carefully weigh against any other alternatives for Medtronic's $15 million.
Medtronic's pledge to invest so far isn't binding, but if it goes ahead this deal might turn out to be a rewarding investment. Ishrak's record is as proven as any executive in his industry and he has colleagues with strong resumes, too.
Maybe it's a sign of how powerful this SPAC boom has become that even industry statesmen such as Ishrak have come up with one.
Compute Health filed to go public last week, with a right to buy into any industry but with an intention to find an acquisition in exactly the line of business its name suggests, at "the intersection of computation and healthcare." Its plan is to sell at least $750 million in stock and warrants to the public.
Last week saw more than two-dozen other new filings by SPACs seeking to go public, a speculative bonanza in SPACs that just keeps rolling. At least 79 have gone public this year already and about 250 of them went public last year, raising more than $100 billion. The vast majority are still empty shells in search of a business to buy.